Invictus RG lowered its holdings in shares of Humana Inc (NYSE:HUM) by 27.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,802 shares of the insurance provider’s stock after selling 668 shares during the quarter. Invictus RG’s holdings in Humana were worth $439,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Koch Industries Inc. acquired a new position in Humana in the 2nd quarter valued at $404,000. Adviser Investments LLC purchased a new position in shares of Humana during the third quarter worth about $635,000. Teachers Advisors LLC grew its holdings in shares of Humana by 31.6% during the second quarter. Teachers Advisors LLC now owns 630,835 shares of the insurance provider’s stock worth $151,792,000 after purchasing an additional 151,603 shares in the last quarter. Prisma Capital Partners LP purchased a new position in shares of Humana during the second quarter worth about $7,122,000. Finally, Federated Investors Inc. PA grew its holdings in shares of Humana by 608.1% during the second quarter. Federated Investors Inc. PA now owns 34,626 shares of the insurance provider’s stock worth $8,331,000 after purchasing an additional 29,736 shares in the last quarter. Institutional investors and hedge funds own 94.19% of the company’s stock.

Shares of Humana Inc (NYSE HUM) traded down $6.25 on Tuesday, reaching $252.28. The company’s stock had a trading volume of 2,500,000 shares, compared to its average volume of 1,386,462. The stock has a market capitalization of $36,933.62, a price-to-earnings ratio of 22.06, a P/E/G ratio of 1.78 and a beta of 0.88. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.61 and a current ratio of 1.61. Humana Inc has a 1-year low of $186.25 and a 1-year high of $264.56.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The firm had revenue of $13.28 billion during the quarter, compared to the consensus estimate of $13.41 billion. During the same quarter in the previous year, the company posted $3.18 earnings per share. The business’s revenue was down 3.0% on a year-over-year basis. equities research analysts anticipate that Humana Inc will post 11.63 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be given a $0.40 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.60 annualized dividend and a yield of 0.63%. Humana’s payout ratio is currently 12.59%.

Several research analysts have recently commented on HUM shares. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $273.00 price objective for the company in a report on Tuesday, October 3rd. ValuEngine raised Humana from a “hold” rating to a “buy” rating in a report on Friday, September 1st. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a report on Wednesday, August 23rd. Deutsche Bank boosted their price objective on Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Finally, Jefferies Group reissued a “hold” rating and set a $257.00 price objective on shares of Humana in a report on Friday, October 13th. Twelve analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $255.45.

ILLEGAL ACTIVITY NOTICE: This article was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this article on another website, it was illegally stolen and republished in violation of international copyright and trademark laws. The legal version of this article can be read at https://theolympiareport.com/2017/12/05/invictus-rg-sells-668-shares-of-humana-inc-hum.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.